Smallpox treatment involves vaccination and antiviral drugs to control smallpox infection. The vaccination helps build immunity against smallpox by getting exposed to a variant of the virus. The targeted drugs directly attack the virus and stop its replication in the body. The increasing prevalence of smallpox globally has raised the demand for effective smallpox treatment options. Moreover, the growing adoption of targeted therapies due to their high efficiency and reduced side effects compared to traditional therapies is fueling the smallpox treatment market growth. The global Smallpox Treatment Market is estimated to be valued at US$ 79.15 Bn in 2024 and is expected to exhibit a CAGR of 27% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The expansion of the targeted therapies segment is one of the major trends being witnessed in the smallpox treatment market. Targeted therapies offer advantages such as directly attacking the virus, rapid replication inhibition, and reduced side effects. With the ongoing research and development, numerous targeted drug formulations are being evaluated for smallpox treatment. This is contributing significantly to market growth. Moreover, targeted therapies are gaining higher acceptance among healthcare professionals and patients compared to conventional therapies. This growing adoption is expected to fuel the targeted therapies segment during the forecast period.

Segment Analysis

The global smallpox treatment market can be segmented based on therapy, route of administration and distribution channel. The therapy segment is further divided into post exposure prophylaxis(PEP) and vaccine immunization. PEP holds the largest market share as it provides immunity after being exposed to smallpox virus. The route of administration segment includes oral and parenteral. Parenteral route dominates as it ensures direct delivery of therapeutics to the bloodstream leading to quick onset of action. Hospitals accounts for the largest share in the distribution channel segment owing to higher patient preference and availability of diagnostic and treatment facilities.

Key Takeaways

The Global Smallpox Treatment Market Growth is expected to witness high growth.

Regional analysis shows that North America holds the major market share currently due to accelerated adoption of new treatment lines and technological advancements in the region. Europe holds the second position and is expected to grow steadily during the forecast period owing to increasing investment in research and development by key players in countries like U.K and Germany.

Key players operating in the smallpox treatment market are 42 Degrees Company, ScaldoPack, Heat Food & Drink Ltd, Luxfer Magtech Inc., HeatGen, LLC., LMK Thermosafe, Kemira Inc, Ontech operations Inc., Com-Pac International.

Get More Insights Here

https://www.newswirestats.com/smallpox-treatment-market-size-share-growth-outlook-2023/